Grifols, S.A. - American Depositary Shares (GRFS)

CEO Abia discusses immunoglobulin growth and Egypt plasma expansion strategy.

Grifols (NASDAQ:GRFS) said its second-quarter and first-half results kept the plasma-derived medicines company on track to meet its 2026 objectives, supported by continued growth in immunoglobulins, improving free cash flow and progress in its plasma-sourcing strategy. Chief Executive Officer Nacho

Kennametal delivers advanced tooling and materials for demanding industrial sectors, leveraging innovation and a global customer base.

As of March 25, 2026, Grifols S.A. (NASDAQ: GRFS) stands at a pivotal crossroads in its century-long history. Once the undisputed champion of the European healthcare sector, the Spanish plasma giant spent much of the last two years fighting for its corporate life following a devastating short-seller attack and a debt-fueled identity crisis. Today, the [...]

Despite a recent pullback, shares are still up big over the past year, and one investor seems to be expecting further upside.

After a sharp post-spin rally, one investor’s trim raises a question about how Millrose fits into long-term housing capital strategies.

A recent portfolio move highlights why scale, recurring revenue, and integration execution may matter more than short-term stock swings.

With shares well off their highs, one fund is leaning into fundamentals that the market may be overlooking.

Grifols (GRFS) stock shows strong technical momentum and explosive earnings growth, fitting a high-growth trend template for potential market leaders.

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial stability in 2024.

Brookfield Asset Management is reportedly pursuing €9.5 billion in debt financing for a potential take-private deal for Grifols. The deal could lead to major financial restructuring, impacting bondholders and shareholders amid scrutiny of Grifols' high debt levels and credit downgrades.

Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro.

Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares.